Robust Detection of Somatic Mosaicism and Repeat Interruptions by Long-Read Targeted Sequencing in Myotonic Dystrophy Type 1

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2021 Apr 3

PMID 33807660

Citations 16

Authors

Antoine Mangin

Laure de Pontual

Yu-Chih Tsai

Laetitia Monteil

Mathilde Nizon

Pierre Boisseau

Sandra Mercier

Janet Ziegle

John Harting

Cheryl Heiner

Genevieve Gourdon

Stephanie Tome

Affiliations

Soon will be listed here.

Abstract

Myotonic dystrophy type 1 (DM1) is the most complex and variable trinucleotide repeat disorder caused by an unstable CTG repeat expansion, reaching up to 4000 CTG in the most severe cases. The genetic and clinical variability of DM1 depend on the sex and age of the transmitting parent, but also on the CTG repeat number, presence of repeat interruptions and/or on the degree of somatic instability. Currently, it is difficult to simultaneously and accurately determine these contributing factors in DM1 patients due to the limitations of gold standard methods used in molecular diagnostics and research laboratories. Our study showed the efficiency of the latest PacBio long-read sequencing technology to sequence large CTG trinucleotides, detect multiple and single repeat interruptions and estimate the levels of somatic mosaicism in DM1 patients carrying complex CTG repeat expansions inaccessible to most methods. Using this innovative approach, we revealed the existence of de novo CCG interruptions associated with CTG stabilization/contraction across generations in a new DM1 family. We also demonstrated that our method is suitable to sequence the DM1 locus and measure somatic mosaicism in DM1 families carrying more than 1000 pure CTG repeats. Better characterization of expanded alleles in DM1 patients can significantly improve prognosis and genetic counseling, not only in DM1 but also for other tandem DNA repeat disorders.

Citing Articles

Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington's disease.

Maestri S, Scalzo D, Damaggio G, Zobel M, Besusso D, Cattaneo E Nucleic Acids Res. 2024; 53(1.

PMID: 39676657 PMC: 11724279. DOI: 10.1093/nar/gkae1155.

Leveraging the power of long reads for targeted sequencing.

Iyer S, Goodwin S, McCombie W Genome Res. 2024; 34(11):1701-1718.

PMID: 39567237 PMC: 11610587. DOI: 10.1101/gr.279168.124.

Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

Seifert B, Reddi H, Kang B, Bean L, Shealy A, Rose N Genet Med. 2024; 26(8):101145.

PMID: 38836869 PMC: 11298302. DOI: 10.1016/j.gim.2024.101145.

Long read sequencing on its way to the routine diagnostics of genetic diseases.

Olivucci G, Iovino E, Innella G, Turchetti D, Pippucci T, Magini P Front Genet. 2024; 15:1374860.

PMID: 38510277 PMC: 10951082. DOI: 10.3389/fgene.2024.1374860.

Sequence composition changes in short tandem repeats: heterogeneity, detection, mechanisms and clinical implications.

Rajan-Babu I, Dolzhenko E, Eberle M, Friedman J Nat Rev Genet. 2024; 25(7):476-499.

PMID: 38467784 DOI: 10.1038/s41576-024-00696-z.

References

Santoro M, Masciullo M, Silvestri G, Novelli G, Botta A . Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis. Clin Genet. 2016; 92(4):355-364. DOI: 10.1111/cge.12954. View

Mitsuhashi S, Matsumoto N . Long-read sequencing for rare human genetic diseases. J Hum Genet. 2019; 65(1):11-19. DOI: 10.1038/s10038-019-0671-8. View

Santoro M, Masciullo M, Pietrobono R, Conte G, Modoni A, Bianchi M . Molecular, clinical, and muscle studies in myotonic dystrophy type 1 (DM1) associated with novel variant CCG expansions. J Neurol. 2012; 260(5):1245-57. DOI: 10.1007/s00415-012-6779-9. View

Brook J, McCurrach M, Harley H, Buckler A, Church D, Aburatani H . Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell. 1992; 68(4):799-808. DOI: 10.1016/0092-8674(92)90154-5. View

Antonio M, Dogan C, Daidj F, Eymard B, Puymirat J, Mathieu J . The DM-scope registry: a rare disease innovative framework bridging the gap between research and medical care. Orphanet J Rare Dis. 2019; 14(1):122. PMC: 6547518. DOI: 10.1186/s13023-019-1088-3. View

Radvansky J, Ficek A, Minarik G, Palffy R, Kadasi L . Effect of unexpected sequence interruptions to conventional PCR and repeat primed PCR in myotonic dystrophy type 1 testing. Diagn Mol Pathol. 2011; 20(1):48-51. DOI: 10.1097/PDM.0b013e3181efe290. View

Martorell L, Johnson K, Boucher C, Baiget M . Somatic instability of the myotonic dystrophy (CTG)n repeat during human fetal development. Hum Mol Genet. 1997; 6(6):877-80. DOI: 10.1093/hmg/6.6.877. View

Joosten I, Hellebrekers D, de Greef B, Smeets H, de Die-Smulders C, Faber C . Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations. Eur J Hum Genet. 2020; 28(7):956-962. PMC: 7316980. DOI: 10.1038/s41431-020-0601-4. View

Morales F, Vasquez M, Corrales E, Vindas-Smith R, Santamaria-Ulloa C, Zhang B . Longitudinal increases in somatic mosaicism of the expanded CTG repeat in myotonic dystrophy type 1 are associated with variation in age-at-onset. Hum Mol Genet. 2020; 29(15):2496-2507. DOI: 10.1093/hmg/ddaa123. View

10.

Hoijer I, Tsai Y, Clark T, Kotturi P, Dahl N, Stattin E . Detailed analysis of HTT repeat elements in human blood using targeted amplification-free long-read sequencing. Hum Mutat. 2018; 39(9):1262-1272. PMC: 6175010. DOI: 10.1002/humu.23580. View

11.

Imbert G, Kretz C, Johnson K, Mandel J . Origin of the expansion mutation in myotonic dystrophy. Nat Genet. 1993; 4(1):72-6. DOI: 10.1038/ng0593-72. View

12.

Lian M, Law H, Lee C, Chong S . Defining the performance parameters of a rapid screening tool for myotonic dystrophy type 1 based on triplet-primed PCR and melt curve analysis. Expert Rev Mol Diagn. 2016; 16(11):1221-1232. DOI: 10.1080/14737159.2016.1241145. View

13.

Flower M, Lomeikaite V, Ciosi M, Cumming S, Morales F, Lo K . MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1. Brain. 2019; . PMC: 6598626. DOI: 10.1093/brain/awz115. View

14.

Paulson H . Repeat expansion diseases. Handb Clin Neurol. 2018; 147:105-123. PMC: 6485936. DOI: 10.1016/B978-0-444-63233-3.00009-9. View

15.

Musova Z, Mazanec R, Krepelova A, Ehler E, Vales J, Jaklova R . Highly unstable sequence interruptions of the CTG repeat in the myotonic dystrophy gene. Am J Med Genet A. 2009; 149A(7):1365-74. DOI: 10.1002/ajmg.a.32987. View

16.

Fontana L, Santoro M, DApice M, Peluso F, Gori G, Morrone A . Identification, molecular characterization and segregation analysis of a variant pre-mutation allele in a three-generation Italian family. Acta Myol. 2020; 39(1):13-18. PMC: 7315898. DOI: 10.36185/2532-1900-002. View

17.

Pesovic J, Peric S, Brkusanin M, Brajuskovic G, Rakocevic-Stojanovic V, Savic-Pavicevic D . Repeat Interruptions Modify Age at Onset in Myotonic Dystrophy Type 1 by Stabilizing Expansions in Somatic Cells. Front Genet. 2018; 9:601. PMC: 6278776. DOI: 10.3389/fgene.2018.00601. View

18.

Cumming S, Jimenez-Moreno C, Okkersen K, Wenninger S, Daidj F, Hogarth F . Genetic determinants of disease severity in the myotonic dystrophy type 1 OPTIMISTIC cohort. Neurology. 2019; 93(10):e995-e1009. PMC: 6745735. DOI: 10.1212/WNL.0000000000008056. View

19.

Overend G, Legare C, Mathieu J, Bouchard L, Gagnon C, Monckton D . Allele length of the DMPK CTG repeat is a predictor of progressive myotonic dystrophy type 1 phenotypes. Hum Mol Genet. 2019; 28(13):2245-2254. PMC: 6586140. DOI: 10.1093/hmg/ddz055. View

20.

Ballester-Lopez A, Koehorst E, Almendrote M, Martinez-Pineiro A, Lucente G, Linares-Pardo I . A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype. Hum Mutat. 2019; 41(2):420-431. DOI: 10.1002/humu.23932. View